================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G/A
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 4)*
Aethlon Medical, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, $.001 PAR VALUE
--------------------------------------------------------------------------------
(Title of Class of Securities)
00808Y109
--------------------------------------------------------------------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
================================================================================
Page 1 of 4 Pages
----------------------------- ------------------------------
CUSIP No. 00808Y109 13G/A Page 2 of 4 Pages
----------------------------- ------------------------------
--------------------------------------------------------------------------------
1. NAMES OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Esquire Trade & Finance Inc.
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
NUMBER OF 115,549 shares of Common Stock
SHARES --------------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY None
EACH --------------------------------------------------------
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON WITH 115,549 shares of Common Stock
--------------------------------------------------------
8. SHARED DISPOSITIVE POWER
None
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
115,549 shares of Common Stock
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES |_|
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.81%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
CO
-------------------------------------------------------------------------------
CUSIP NO. 00808Y109 PAGE 3 OF 4 PAGES
--- ---
ITEM 1 (a) NAME OF ISSUER: Aethlon Medical, Inc.
ITEM 1 (b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
7825 Fay Avenue, Suite 200, La Jolla, CA 92037
ITEM 2 (a) NAME OF PERSON FILING: Esquire Trade & Finance Inc.
ITEM 2 (b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
Trident Chambers, Road Town, Tortola, B.V.I.
ITEM 2 (c) CITIZENSHIP: British Virgin Islands
ITEM 2 (d) TITLE OF CLASS OF SECURITIES: Common Stock, $.001 par value
ITEM 2 (e) CUSIP NUMBER: 00808Y109
ITEM 3 IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B) OR
13D-2(B): Not applicable
ITEM 4 OWNERSHIP
(a) AMOUNT BENEFICIALLY OWNED: 115,549 Shares of Common Stock
(b) PERCENT OF CLASS: 0.81%
(c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
(i) SOLE POWER TO VOTE OR DIRECT THE VOTE
115,549 Shares
(ii) SHARED POWER TO VOTE OR DIRECT THE VOTE
0 Shares
(iii) SOLE POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF
115,549 Shares
(iv) SHARED POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF
0 Shares
CUSIP NO. 00808Y109 PAGE 4 OF 4 PAGES
--- ---
ITEM 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
As of the date hereof, Esquire Trade & Finance Inc reports that it has ceased
to be the beneficial owner of more than five percent of any class of securities
of Aethlon Medical, Inc.
ITEM 6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not applicable
ITEM 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
Not applicable
ITEM 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A GROUP
Not applicable
ITEM 9 NOTICE OF DISSOLUTION OF GROUP
Not applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 10, 2005
----------------------------------------
(Date)
/s/ Francois Morax
----------------------------------------
(Signature)
Francois Morax, Director
----------------------------------------
(Name/Title)